GPP

Great Point Partners Portfolio holdings

AUM $154M
1-Year Est. Return 2.36%
This Quarter Est. Return
1 Year Est. Return
-2.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$637M
AUM Growth
+$3.94M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
42
New
Increased
Reduced
Closed

Top Buys

1
+$28.5M
2
+$18M
3
+$16.7M
4
EXEL icon
Exelixis
EXEL
+$13.1M
5
VYNE icon
VYNE Therapeutics
VYNE
+$12.8M

Top Sells

1
+$40M
2
+$34.8M
3
+$22.3M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$16.7M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$13.7M

Sector Composition

1 Healthcare 96.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$1.8M 0.28%
+58,461
27
$834K 0.13%
12,271
-44,752
28
$153K 0.02%
8,676
29
$46K 0.01%
21,441
-1,515,579
30
– –
-52,841
31
– –
-759,494
32
– –
-53,632
33
– –
-713,998
34
– –
-340,784
35
– –
0
36
– –
0
37
– –
-770,400
38
– –
-302,000
39
– –
-110,506
40
– –
-2,988,716
41
– –
-2,500
1
2